Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
question answered ... thank you...
dmiller sold with most of his shares being short term ( trading shares ) and JL sold more than 50% of his shares that were long term..... both feel that AMARIN is a questionable holding, and has significant chance to fail...
Now you can all make your decision of whats prudent for you.....
I'm not asking a hard question.... by percentage (x) long and (x)short.....I'm not asking the price or the amount of shares, only the percentage.... it's great you made a profit...
Your a day trader for the most part .... and for those with long term capital holdings of AMARIN, selling would not be prudent... how many shares you were holding of the 75% you sold were short term or long term??? That would be valuable to this board of your trading practices...
2nd time I've posted on this subject....in the last two years
6 times in the last two plus days ( clay trader ) has posted the same same exact posting.... this is to let his supporters of day traders know where the low is to be tested the next day.... in this case it is $17.15 by his post starting on Friday night.... we didn't here from him for over a week or two and then here he again showing up..... it only takes a group of day traders with 1-2 mil shares to play with this stock as evidenced if you follow his ongoing postings....
Thank you....
Mylan's case was about "OBVIOUSNESS"..... Stating that BIOGEN'S drug results were obvious, because the 360mg didn't show great results and the 720mg showed no results, but low and behold the middle dosage gave great results... and that was obvious to any layman... not hardly...
This case and verdict will be before JUDGE DU when deciding Amarin's case...
For those with sometime on your hands..... read the news articles concerning the BIOGEN- MYLAN lawsuit today.... Mylan ( generic ) filed to invalidate Biogen's 514 patent... The court ruled that Mylan failed to produce a preponderance of evidence to support their case to invalidate the patent,... looks exactly like Amarin's court case.... it also reflects how multiple lawsuits were filed by generics for different reasons to invalidate the patent.... THIS serves to show why Amarin and its legal team wants to squash generics to stop possible new lawsuits and settlements...
I don't care what your gains have been... it's great that you made positive gains..... I care what information is transmitted to this board and that is not FOOLISH....
Thanks for answering my question... but i believe you bought more in the $18-22 dollar range, since your postings started around Nov 11, 2018... you've been in now over a year without any real return with the stock market up 20-30% .... so you sold... this board should have all the facts, since you don't post IMO (IN MY OPINION).... EVERY INVESTOR has to make their own decision when to buy-sell, but investors on this board depend on good solid information to help in their decision process.
Thats not what I posted...I said you bought in 2013-2014 at about a dollar and sold when it was in the $3.00 range and bought back after SEPT 2018 approval and now sold 75% of your holdings.... don't skirt what I was implying... answer what I stated... please give us the platform you posted to from 2013 -2018..... someone one with your memory would not forget the platform with over 12000 postings... by the way you stated you bought motorola in the fifties, when you were in your teens...
dmiller..
I've read your postings.... many since OCT 2018 after approval .... no postings on AMARIN for years Sept 2018 to 2013... What is your end game???
Who are you trying to impress???? sell the last 25% and move into the other stock that will quadruple...yes you bought at less than a dollar, but sold when it reached over $3.00 dollars, because you are a trader for the most part... you're over 80 yrs old, take time to enjoy your remaining years... you quote nebulous positions.. what is your core price on AMARINS remaining 25%...
Let me guess.. you bought in 2013-2014 sold and bought in 2018 again and now your out 75%in early 2020...
Remember..... all his picks are winners..... has't lost on any..... I believe he made something on AMARIN... just sold 75% of his holdings .... he is a trader mostly doesn't hold long term... Amarin was a short term trade...
What an inspiration for this board.....
dmiller
The caller, not CRAMER shed a positive view of Amarin in national program....I have called out Cramer by contacting CNBC over ten times in the last 7 years .... he has gone from degrading Amarin to now applauding Amarin over time... He is of no consequence and his views are irrelevant...
The Caller's statement was relevant and Cramer had to respond positively....
Meanwhile you consider yourself a Realist and generally post more negative than positive responses to this board... do some research and come up with something positive...
dmiller
At least he got Amarin's name out there in a positive way.... 25% mace ,buyout speculation, etc... AND elicited a positive response from Cramer on national television.....
What have you done to get Amarin's name out there in a POSITIVE VIEW ???
Profits101
Thank you for your response ... I didn't know you and RAF were posting from information received from same individual (TheWyseKid) from ST...
This is why the defendants were asking for documents /posters to be submitted to the court case on 01-28-2020.... the defendants are asserting bias, because of payments to DR's Toth & BUDOFF by AMARIN over a period of years for work they do as paid consultants.....
Vubru, post 243794... this is a little different than what you posted.... it would seem the defendants are crying foal on AMARIN for high paid guns...
Judge Du will not be persuaded with this information.... Expert testimony is expert testimony.... HDG keeps reminding everyone not to jump to conclusions without all the information being fully presented...
profits101
Do you have any updates from that individual that was attending the court case for 1-27 and 1-28... those earlier posts were very informative concerning how that individual saw things happening in the court room ... perceptions... concerning the defendants body lanquage ,etc ... if you can find out thst would be great.... thanks for the DD...
HDG
I believe you might be low concerning Canadian 2020 sales.... they are notorious for selling product (drugs) to the US market by simply shipping thru US mail... their double digit royalties deal with AMARIN will not make AMARIN take issue... Canadian drug chains have been doing this consistently ....just look at VIAGRA sales the last 15 yrs...
TTE
Maybe someone comes up with that one little piece of information that changes everything..... keep searching, you never know....
HDG
Review BB's posting #238228, on 01-02-2020, at 2:59:40 concerning " NEW PACER JUDGE RULES ON OLDER MOTION, etc . "
Halfway thru posting it talks about Dr. Peck and other witness's allowed and not allowed by both sides...
This week....
Last friday we saw short interest decline, but still large enough to get caught in a short squeese...
Monday, two competitors failed in their outcomes... eliminates competition
Today, we saw scripts move up to near all time highs and substantial increase from 2019
Today, we saw #approx. 350,000 calls/puts ( representing 30 to 35 mil shares ) hold the price to a $20.00 market valuation.... these players made money.... options forward are substantially lower for all months, leaving weekly players out there..
Market sees court case going according as expected .... see analysts written evaluations on the subject...
Without big market manipulation next week. we should see PPS INCREASE UPWARD....
IMO only...
The court case ongoing .... the Judge reviewing both sides.... WHAT would be a main factor concerning inducement ???? SCRIPTS SCRIPTS SCRIPTS
Todays number clearly reflects the potential of VASCEPA and thus what the generics could clearly gain from having a label identical to AMARINS.... I'm not saying the new labeL, but just having the MARINE label would give them off label sales, since pharmacies would substitute to generics ....
FDA will never police the label differences between REDUCE-IT vs MARINE.
Lets hope Judge Du comes to that same conclusion....
Bio
PFE, CEO was on CMBC today at around 2:30 pm and stated they were looking at phase 2 /phase 3 biotechs not bolt on companies....
If Hikma mentioned Amarin/ Vascepa by name at the JPM conference in discussions, please forward it to Elisabeth, IR ... the amount you indicated does represent more than high trig scripts...
Acasti , capre trial,trilogy 1 :
This twelve week study enrolled approx. 250 patients in 54 sites ( this is like 5 patients per site ) .... they claim that 5 sites had high PLACEBO percentages..... Must have been tough to follow on going results from such a large group... Good luck with explaining this to the FDA....
CHAS:
Are you in Reno,NV at the court hearings.... this post gives that impression... if so.... what was your take on court proceedings today.
Mets:
First of all want to thank Hamoa, post #240118... he captures the essence of this case and why AMARIN should prevail...
Next: this post concerning motions 333,334,335,336... Judge Du has stated and demonstrated wanting an OPEN CASE to be brought to her court...
On Jan.6 all parties submit under motion #333 their cases ( finding of facts ) facts agreed upon by both parties and those not agreed upon)... facts agreed upon are not presented during the trial... On JAN 7 the defendents ( GENERICS) file motion #334 to seal portions of documents submitted under motion #333 .... Relocatedmetsfan see the motion in your posting has sections blacked out ( redacted ).... now that motion has Redacted and Unredacted portions...
Judge Du denies motion #334 and on Monday, Jan.13 AMARIN will see the whole findings of fact (generics full case to be presented in court) laid out in it's entirety..... Judge Du then presents to AMARIN weather they want the unredacted parts of motion #333 to be sealed and if so why.... if AMARIN does not request sealing, then the trial will be an open case for both parties since the defendents case can be reviewed.... Amarin has two days to see how trial is shaping to make the decision.... looks to be in their benefit...
HDG:
I didn't get into added interest ( PLUS $650 cash ), stock option allocations, debt reduction,etc. just looking at sales increase from 3rd qtr : plus $28mil less cogs ,etc. but looking at increased cash usage for inventory/acct rec, etc .... AMARIN should be profitable by apprOx. $4mil or $.01 for the qtr... the PR from AMARIN gave an impression that we lost for the quarter, is what I was looking at....
The PR also stated that operating expenses would be up by $299-250 MIL.... and no corresponding stated media/increased payroll allocations,etc... profitability or loss depends on many expenses, but does not take in effect if sales ramp up like this yr's 85%... the market likes positive indications.... always has.
2019 financial update: per AMARINS's PR
quarterly sales $140-141mil. or $426 mil total for 2019.....approx. 85%
Amarin stated as follows:
$645.mil cash end of yr vs $673.mil end of 3rd qtr. = less $28mil
$76.mil inv. end of yr vs $54.mil end of 3rd qtr = plus $22.mil
$117.mil acct rec. end of yr vs $103 mil end of 3rd qtr =plus 14 mil.
total diff. plus $8mil eoy
AMARIN should post earnings ( profit ) of $.01 to $.00 for 4th qtr .
sts66
read the PR again.... he said additional outgoing cash flows of approx. 28mil for the quarter.... reps at best (266 reps x 1500.wk x 12 wk = 5MIL )... This was just part of the outflow... REMEMBER we have 20-25mil. additional sales from the 3rd quarter....
ppnlf
Yes it posted sales of #600000 shares the green only meant the this trade was done at a higher price than the previous trade...
Stay the course.... stay vigilant
Patents will be addressed today and on 01-09-2020.... with the court trial beginning on 01-13-2020.... if no settlement, then we know that either the Dietary industry or BP is funding these generics throughout the trial and possible a repeal process...
The trial deals with Obviousness and Inducement.....
Mochida Corp initiated the Jelis Trial in 2003 and brought Late Breaking Clinical Trial results to the AHA CONF. in NOV. 13-16 ,2005. Have to believe that JZ ( Zakrzewski ) and his scientific dept. picked up on the relevance of a secondary indication of 19% CV reduction benefit, but not stag sig. using high doze of EPA/STATIN. They become innovator's of a drug with 97-98% EPA molecule purity in high dozes called VASCEPA.... They put together two trials called MARINE & ANCHOR while submitting patents on both (starting in 2007/2008 )... discussions with the FDA linking the lowering of CV events.. Amarin wants approval for VASCEPA and puts forth the lowering of TRIG'S over #500 (MARINE TRIAL) that will treat a disease known as PANCREATITUS, even though lowering CV events is the main focus.... they work with FDA on approval of ANCHOR TRIAL (trig's between 200-499 ), but FDA wants a CVOT trial called Reduce-it with 50% enrollment before approval... the ANCHOR indication was always about lowering CV events... We know how the ADCOM and ANCHOR approval went in 2013 with CRL IN 2016.... the FDA gave Amarin a 3 yr.approval and not NCE a 5 yr approval ( corrected in court in 2016 ) but the generics filed their SDNA'S in 2016... Teva settled, but these other generics continued with depositions taken in 2016/2017..... here we are today...no one could calculate what the Reduce-it trial results would be.
Amarin Corp. must win the OBVIOUNESS validity portion of this lawsuit in TWO parts... the generics concentrated originally on invalidating the MARINE patents by "WRITTEN DESRIPTION" ,but when that motion was turned down by Judge Du, they followed up with OBVIOUSNESS/INDUCEMENT... the generics are fighting on two fronts (1) IF they lose OBVIOUS outright, they presented the argument to Judge Du that AMARIN'S expert witness in deposition stated he discontinued scripts to 5% of his patients in 5 weeks...the Judge stated that 5% is considered LARGE... The generics are contending that 5% of a population of 5mil. patients with high trig's equals 250,000 patients and unmet need to treat... AMARIN counter's with high trig's is a chronic disease ongoing, that physicians will write continuous scripts to treat patients. CHRONIC equals CONTINUATION. No information available why there was a 5% discontinuation of scripts by expert witness a physician... Judge Du leans to Amarin concerning NON-OBVIOUSNESS ,but must reject generics on unmet need pro-offered to give them the same label as MARINE indication for patients with trig's over #500. This is why she wants settlement... so no decision is needed...
If Judge Du sides with AMARIN on both issues above then INDUCEMENT is irrelevant... but if she sides with the generics on either above issue then AMARIN must win INDUCEMENT... Generics will claim they will adhere to MARINE labeling with physicians, but have no control of pharmacies accepting OFF-LABEL because generics will presumably have lower prices than AMARIN .... and we know the push for generics in the marketplace today...
Once this overhang is alleviated, we are only concerned with script growth and how JT makes VASCEPA a standard of treatment.
Stay the course.... stay vigilant
Patents will be addressed today and on 01-09-2020.... with the court trial beginning on 01-13-2020.... if no settlement, then we know that either the Dietary industry or BP is funding these generics throughout the trial and possible a repeal process...
The trial deals with Obviousness and Inducement.....
Mochida Corp initiated the Jelis Trial in 2003 and brought Late Breaking Clinical Trial results to the AHA CONF. in NOV. 13-16 ,2005. Have to believe that JZ ( Zakrzewski ) and his scientific dept. picked up on the relevance of a secondary indication of 19% CV reduction benefit, but not stag sig. using high doze of EPA/STATIN. They become innovator's of a drug with 97-98% EPA molecule purity in high dozes called VASCEPA.... They put together two trials called MARINE & ANCHOR while submitting patents on both (starting in 2007/2008 )... discussions with the FDA linking the lowering of CV events.. Amarin wants approval for VASCEPA and puts forth the lowering of TRIG'S over #500 (MARINE TRIAL) that will treat a disease known as PANCREATITUS, even though lowering CV events is the main focus.... they work with FDA on approval of ANCHOR TRIAL (trig's between 200-499 ), but FDA wants a CVOT trial called Reduce-it with 50% enrollment before approval... the ANCHOR indication was always about lowering CV events... We know how the ADCOM and ANCHOR approval went in 2013 with CRL IN 2016.... the FDA gave Amarin a 3 yr.approval and not NCE a 5 yr approval ( corrected in court in 2016 ) but the generics filed their SDNA'S in 2016... Teva settled, but these other generics continued with depositions taken in 2016/2017..... here we are today...no one could calculate what the Reduce-it trial results would be.
Amarin Corp. must win the OBVIOUNESS validity portion of this lawsuit in TWO parts... the generics concentrated originally on invalidating the MARINE patents by "WRITTEN DESRIPTION" ,but when that motion was turned down by Judge Du, they followed up with OBVIOUSNESS/INDUCEMENT... the generics are fighting on two fronts (1) IF they lose OBVIOUS outright, they presented the argument to Judge Du that AMARIN'S expert witness in deposition stated he discontinued scripts to 5% of his patients in 5 weeks...the Judge stated that 5% is considered LARGE... The generics are contending that 5% of a population of 5mil. patients with high trig's equals 250,000 patients and unmet need to treat... AMARIN counter's with high trig's is a chronic disease ongoing, that physicians will write continuous scripts to treat patients. CHRONIC equals CONTINUATION. No information available why there was a 5% discontinuation of scripts by expert witness a physician... Judge Du leans to Amarin concerning NON-OBVIOUSNESS ,but must reject generics on unmet need pro-offered to give them the same label as MARINE indication for patients with trig's over #500. This is why she wants settlement... so no decision is needed...
If Judge Du sides with AMARIN on both issues above then INDUCEMENT is irrelevant... but if she sides with the generics on either above issue then AMARIN must win INDUCEMENT... Generics will claim they will adhere to MARINE labeling with physicians, but have no control of pharmacies accepting OFF-LABEL because generics will presumably have lower prices than AMARIN .... and we know the push for generics in the marketplace today...
Once this overhang is alleviated, we are only concerned with script growth and how JT makes VASCEPA a standard of treatment.
Please send this information to Elisabeth in IR..... if the US government considers this a chronic problem, then the US Courts should also consider it chronic..... like on the movie MIRACLE ON 42ST....
Tomorrow we should here that OPPENHEIMER'S analyst raises AMARIN'S target price to $9.00 since it eliminates one of our competitors.....
Mr Joseph Zakrzewski has accepted a new position as Chairman of the BOARD for a company call Cerecin Corp which is running trials for Alzheimers disease.... no statement whether he will remain on Amarin Corp's BOD or will resign...
My apology..... I tend to react without consideration... my apology again
This week was trying considering the downturn on approval..... patience is considered a virtue.... in time this stock will be reward us....
The fact is we need posters to bring constructive thoughts, DD(due diligence), research, factual info on other studies, other competitors, etc.... WHAT we don't need is whiners....what do they bring to this board if everything they post is negative whining about JT, AMARIN, the market, each other...look at the thought processes today concerning patents, that constructive...
Sure you did.... I truly believe that you really think you bought shares in 2018....started posting in Jan. 13 2019 .. have over 1150 posts to date ... where were you the last 3 months of 2018... your posts all almost always negative..... your am options player...
Back again and still whining..... did SANTA kick you off his lap today ????
Please enjoy your retirement.... you earned it..
Mark:
Back again whining about BO.... why not sell your shares, since you have made 1000+% from your average price of $1.85 ... you can by ASCT/MTHN for about the same price as AMARIN $1.85, staying in the same omega3 indications .... pocket the difference for your retirement,since you've been investing more than 45 yrs making you in your late seventies or early eighties... we are hear to help you so that your blood pressure stays normal...allowing you a life you deserve...